Cargando…
SARS‐CoV‐2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California
The SARS‐CoV‐2 (COVID‐19) pandemic continues to affect many lives globally. Patients with cancer undergoing potentially immunosuppressive therapies appear to be at particular risk for the disease and its complications. Here, we describe the experience of patients with cancer within Kaiser Permanente...
Autores principales: | Anantharaman, Archana, Dusendang, Jennifer R., Schmittdiel, Julie A., Harzstark, Andrea L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753632/ https://www.ncbi.nlm.nih.gov/pubmed/33210439 http://dx.doi.org/10.1002/onco.13602 |
Ejemplares similares
-
Prior Immunosuppressive Therapy and Severe Illness Among Patients Diagnosed with SARS-CoV-2: a Community-Based Study
por: Velayos, Fernando S., et al.
Publicado: (2021) -
Association of anticoagulation use with SARS-CoV2 detection()
por: Kavecansky, Juraj, et al.
Publicado: (2021) -
SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
por: Gubatan, John, et al.
Publicado: (2020) -
Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients
por: Ho, Gwendolyn, et al.
Publicado: (2021) -
Identifying Predictors of Homelessness Among Adults in a Large Integrated Health System in Northern California
por: Rodriguez, Luis A, et al.
Publicado: (2023)